ArticleAmerican journal of industrial medicine2025
Exposure Registries as a Prevention Tool for Occupational Cancers: Establishing a New Hazardous Drug Registry for Oncology Personnel.
Article in American journal of industrial medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Public health registries collect and maintain demographic and health data on a cohort of people with a common disease or exposure. While disease registries have proliferated in recent decades, registries comprising persons with potentially hazardous exposures-known commonly as exposure registries-are rare. Occupational exposure registries allow for hazardous work exposures to toxicants, including carcinogens, to be systematically tracked to facilitate preventive and mitigating interventions for exposed workers. However, the virtual absence of such registries, combined with the fact that state-based cancer registries do not systematically collect occupational or other exposure information, hinders efforts to study the role of occupation in US cancer cases or undertake appropriate medical surveillance for exposed workers. Given the considerable, and under-recognized, risk of occupational cancer, exposure registries focused on workplace carcinogens could fill this gap. A recent initiative at the authors' home institution has established a national exposure registry of oncology personnel handling hazardous drugs, most notably antineoplastic drugs, many of which are themselves known human carcinogens. The registry aims to facilitate the comprehensive collection of data on exposure scenarios; aid in raising awareness of, and tracking compliance with, best practices in hazardous-drug handling to mitigate risks; and assess long-term cancer, reproductive, and other potentially exposure-associated health outcomes in this worker population. Occupational exposure registries are an underutilized tool in occupational health surveillance. The development of such a registry for hazardous drug exposures is a feasible and scalable model for registry development in other high-risk work environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.